Detalhe da pesquisa
1.
Trehalose, an mTOR-Independent Inducer of Autophagy, Inhibits Human Cytomegalovirus Infection in Multiple Cell Types.
J Virol
; 90(3): 1259-77, 2016 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26559848
2.
25-Hydroxycholesterol activates the integrated stress response to reprogram transcription and translation in macrophages.
J Biol Chem
; 288(50): 35812-23, 2013 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24189069
3.
Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen.
Blood
; 119(10): 2293-301, 2012 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22234695
4.
Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease.
J Virol
; 85(7): 3461-72, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21270160
5.
Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge.
PLoS Negl Trop Dis
; 16(7): e0010588, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35793354
6.
Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.
PLoS Negl Trop Dis
; 15(3): e0009195, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711018
7.
A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
Vaccine
; 38(1): 79-89, 2020 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31611098
8.
Development of cell lines that provide tightly controlled temporal translation of the human cytomegalovirus IE2 proteins for complementation and functional analyses of growth-impaired and nonviable IE2 mutant viruses.
J Virol
; 82(14): 7059-77, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18463148
9.
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge.
Vaccine
; 30(46): 6541-6550, 2012 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22947141
10.
DNA immunization using highly conserved murine cytomegalovirus genes encoding homologs of human cytomegalovirus UL54 (DNA polymerase) and UL105 (helicase) elicits strong CD8 T-cell responses and is protective against systemic challenge.
J Virol
; 81(14): 7766-75, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17507492
11.
Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus.
J Immunol
; 176(6): 3760-6, 2006 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16517745
12.
Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.
J Virol
; 79(1): 159-75, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15596812
13.
Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge.
J Virol
; 76(5): 2100-12, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11836387
14.
Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
J Virol
; 78(20): 11233-45, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15452242
15.
Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
J Virol
; 76(10): 4822-35, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11967299